Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Patient Experiences of Use of Point-of-Care Ultrasound in General Practice

11 de dezembro de 2018 atualizado por: Camilla Aakjær Andersen, Aalborg University

Patient Experiences of Use of Point-of-Care Ultrasound in General Practice: A Questionnaire Study

This study in part of a larger cohort study (clinical trials ID number: NCT03375333) that examine the use of ultrasound in general practice.

In the present study patient experiences, with use of ultrasound in the consultation at the general practitioners office, will be explored through a questionnaire.

Visão geral do estudo

Status

Concluído

Descrição detalhada

This study is a Cross-sectional study, which is conducted as part of a larger cohort study: How Point-of-Care Ultrasound (POC-US) Affects the Diagnostic Process in General Practice. A prospective follow-up study. (Clinical trials registration number: NCT03375333)

Study setting:

The study will take place in 20 different general practices in Denmark where the general practitioners (GPs) use POC-US.

Interventions There is no intervention in this study. The registration in this study will reflect GPs routine daily use of POC-US not adding more examinations or in other ways influence on the treatment of patients.

Sample size Twenty general practitioners (GPs) are expected to use POC-US 2-3 times a day, and assuming a participation rate of 80%, there will be between 640-960 US scan during the study period of one month.

Recruitment All patients who consult the participating GP for conditions relevant for a POC-US examination will be offered to participate in the study. Patients are excluded if they do not wish to participate or if they are not able to give an informed consent.

Patients must provide written, informed consent before any study procedures occur. Only patients assigned to the GPs practice can participate in the study.

Data collection method After the consultation in the GP's office, patients will be asked to fill out a questionnaire about their experience with POC-US in the consultation. The GPs will provide the patients with a unique ID-number and a link to an online questionnaire on the SurveyXact server. The patients will access the online questionnaire using this ID-number through Ipads or on a paper edition.

Baseline information regarding the participating GPs will be provided through the original study. Baseline questions about the patients will be part of the patient-questionnaire following the consultation.

The items in this questionnaire are generated from a qualitative interview study with GPs working in general practice and using POC-US. The items are the GPs expressed believes and concerns about how ultrasound was experienced by their patients.

This questionnaire is developed through the following steps:

  1. A first edition of the questionnaire is developed based on the results of a qualitative interview study with Danish GPs on their experiences on how ultrasound can be used in general practice.
  2. To test face validity, comprehension and wording of the questionnaire, pilot tests are done with laypeople and patients,using the "think-aloud" technique and cognitive interviewing. The pilot-tests are done in two geographical-separated clinics including five patients in each clinic. Adaptions and rephrasing follow after the results are compared.
  3. A validation test will include presenting the rephrased questions from the pilot-tests to 5 GPs, who use ultrasound, and asking them to compare the phrased questions to the original items from the qualitative interviews. Adaptions will follow.
  4. A final pilot-test will include interviews with patients, who have been ultrasound scanned in two other clinics using the "Think-aloud" technique. In this pilot-test the patients are presented to both a paper-version and an online-version of the questionnaire, to test functionality and feasibility. Pilot-tests and adaptions will continue until the questionnaire is completed without difficulties.

Retention Participant Retention GPs will be asked to register not-included patients, in whom POC-US was used during the study period, on a separate form and to declare the reason for the failed inclusion of the patient.

Participant Withdrawal Participating GPs and patients may withdraw from the study for any reason at any time.

Data management Data will be saved electronically in the SurveyXact server and on a server at Aalborg University and will only be accessed by the research group using passwords.

The Research Unit for General Practice in Aalborg is the Data Controller. Each participating GP will be data processor and can only process data pursuant to an agreement with the data controller. A data processor agreements will be made between the Research Unit for General Practice in Aalborg and each participating GP, between the Research Unit for General Practice in Aalborg and Aalborg University, and between Aalborg University and SurveyXact according to the Danish Data Protection Agency recommendations.

The Key files identifying the patients will be safely stored at the GPs office and the research group will not have access to this information during the study.

Statistics The questionnaire data will be collected on an ordinal scale and reported descriptively using frequencies. The correlation between the GPs reported confidence in the tentative diagnosis on a numeric rating scale from 1-5 perceived at an ordinal scale and patients reported experience of ultrasound in the consultation will be compared using scatterplots and Goodman and Kruskal's gamma will be used to test association.

Data monitoring During the study period the research team will be able to observe if the GPs include patients in the study and make contact to the GPs who fail to include patients in order to help out with any difficulties.

Harms All adverse events occurring during the study will be registered.

Research ethics approval The studies are approved by the Danish Data Protection Agency and the Committee of Multipractice Studies in General Practice in Denmark.

Consent or assent Prior to participation, patients will receive written and oral information and a written consent to participate will be obtained.

If a GP or a patient wished to redraw their consent to participate in the study, the GP will contact the research team and no further data will be collected.

Protocol amendments Will be declared and all editions and changes in the protocol will be saved.

Confidentiality All participating GPs have signed a confidentiality agreement.

Declaration of interest None

Access to data Only the Research team will have access to data.

Tipo de estudo

Observacional

Inscrição (Real)

579

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Aalborg, Dinamarca, 9220
        • Research unit for general practice in Aalborg,department of clinical medicine Aalborg university

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

The study will take place in 20 different general practices in Denmark where the GPs use POC-US. The participating GPs will try to include all patients were they use POC-US in the consultation.

Patients must provide written, informed consent before any study procedures occur (see Appendix 1 for sample Informed Consent Form). Only patients assigned to the GPs practice can participate in the study.

Descrição

Inclusion criteria:

- All patients, who the GP intends to examine with POC-US.

Exclusions criteria:

  • Patient not willing or able to give informed consent
  • Patients previously included in the study

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Modelos de observação: Coorte
  • Perspectivas de Tempo: Transversal

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Information
Prazo: assessed immediately after the ultrasound examination

This domain will be explored through the following questions:

Were you informed about the purpose of the ultrasound examination? Were you informed about the difference between a specialist ultrasound and a GP ultrasound? Were you informed about the result of the ultrasound examination?

assessed immediately after the ultrasound examination
Influence on the consultation
Prazo: assessed immediately after the ultrasound examination

This domain will be explored through the following questions:

Did you think the ultrasound examination was a natural part of the consultation? Did you think the ultrasound examination was disruptive in the consultation? Did the ultrasound examination influence the relationship between the GP and you? Do you think ultrasound made a difference in the consultation?

assessed immediately after the ultrasound examination
Diagnostic reassurance
Prazo: assessed immediately after the ultrasound examination

This domain will be explored through the following questions:

Do you feel more thoroughly examined after the ultrasound examination? Do you have a better understanding of your health problem after the ultrasound examination? Do you feel more at ease after the ultrasound examination? Has your confidence in the GPs diagnosis changed after the ultrasound examination? Has the ultrasound examination changed your feeling of being taken seriously?

assessed immediately after the ultrasound examination
Patient satisfaction
Prazo: assessed immediately after the ultrasound examination

This domain will be explored through the following questions:

Was your overall experience with ultrasound in the GP's office positive or negative? Would you recommend ultrasound in the GPs office to others? Do you think ultrasound is a service improvement in the GP's office? Do you think ultrasound is a quality improvement in the GP's office?

assessed immediately after the ultrasound examination

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Associations between GP confidence in the diagnosis and patients sense of diagnostic reassurance
Prazo: assessed immediately after the ultrasound examination
Association between GPs declared confidence in the tentative diagnosis after using ultrasound in the consultation (data from the original cohort expressed on a scale from increased confidence to decreased confidence) and patients' answers to the question "Has your confidence in the GPs diagnosis changed after the ultrasound examination?" expressed on a scale from decreased to increased confidence.
assessed immediately after the ultrasound examination
Associations between GP confidence in the diagnosis and patients experience of improved care
Prazo: assessed immediately after the ultrasound examination
Association between GPs declared confidence in the tentative diagnosis after using ultrasound in the consultation (expressed in the original cohort on a scale from increased confidence to decreased confidence) and patients' answers to the question "Do you feel more at ease after the ultrasound examination?" expressed on a scale from less at ease to more at ease.
assessed immediately after the ultrasound examination

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Cadeira de estudo: Martin Bach Jensen, Professor, GP, PhD, Aalborg University

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

15 de janeiro de 2018

Conclusão Primária (Real)

1 de setembro de 2018

Conclusão do estudo (Real)

2 de setembro de 2018

Datas de inscrição no estudo

Enviado pela primeira vez

10 de janeiro de 2018

Enviado pela primeira vez que atendeu aos critérios de CQ

29 de janeiro de 2018

Primeira postagem (Real)

31 de janeiro de 2018

Atualizações de registro de estudo

Última Atualização Postada (Real)

12 de dezembro de 2018

Última atualização enviada que atendeu aos critérios de controle de qualidade

11 de dezembro de 2018

Última verificação

1 de dezembro de 2018

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • GULD-patient questionnaire

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

Indeciso

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever